Rapid-onset opioids (ROOs) are effective treatments for breakthrough cancer pain (BTcP) given their rapid onset of action and relatively short duration of analgesia. The aim of this article is to describe specific considerations for the use of ROOs in daily practice, focusing on dose titration and treatment of specific populations.
Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily Practice
Bossi, Paolo;
2022-01-01
Abstract
Rapid-onset opioids (ROOs) are effective treatments for breakthrough cancer pain (BTcP) given their rapid onset of action and relatively short duration of analgesia. The aim of this article is to describe specific considerations for the use of ROOs in daily practice, focusing on dose titration and treatment of specific populations.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
PMID 35721659 Rapid-Onset Opioids for Management of Breakthrough Cancer Pain Considerations for Daily Practice.pdf
accesso aperto
Tipologia:
Full Text
Licenza:
DRM non definito
Dimensione
199.68 kB
Formato
Adobe PDF
|
199.68 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
